These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1823637)

  • 41. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
    Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
    Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM.
    Samuelsson U; Ludvigsson J; Sundkvist G
    Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth.
    Ziegler AG; Hillebrand B; Rabl W; Mayrhofer M; Hummel M; Mollenhauer U; Vordemann J; Lenz A; Standl E
    Diabetologia; 1993 May; 36(5):402-8. PubMed ID: 8314444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship of islet cell and islet cell surface antibodies to the presentation and early course of IDDM in childhood.
    Daneman D; Sochett E; Pak CY; Yoon JW
    Diabetes Res Clin Pract; 1988 Jan; 4(2):127-32. PubMed ID: 3277828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children.
    Elamin A; Omer MI; Tuvemo T
    Diabetes Res Clin Pract; 1992 May; 16(2):91-6. PubMed ID: 1600856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.
    Bingley PJ
    Diabetes; 1996 Dec; 45(12):1720-8. PubMed ID: 8922357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
    Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
    J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin autoantibodies as determined by competitive radiobinding assay are positively correlated with impaired beta-cell function--the Ulm-Frankfurt Population Study.
    Yassin N; Seissler J; Glück M; Boehm BO; Heinze E; Pfeiffer EF; Scherbaum WA
    Klin Wochenschr; 1991 Oct; 69(16):736-41. PubMed ID: 1762378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.
    Park Y; Lee H; Takino H; Abiru N; Kawasaki E; Eisenbarth GS
    Acta Diabetol; 2001; 38(1):51-6. PubMed ID: 11487177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
    Majkowska L
    Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantification of human cytoplasmic islet-cell antibodies which cross-react with mouse pancreas: a follow-up study in type 1 (insulin-dependent) diabetic patients and in first-degree relatives.
    Saï P; Elmansour A; Audrain M; Charbonnel B; Bardet S
    Diabetologia; 1993 Aug; 36(8):778-84. PubMed ID: 8405747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.
    Harrison LC; Chu SX; DeAizpurua HJ; Graham M; Honeyman MC; Colman PG
    J Clin Invest; 1992 Apr; 89(4):1161-5. PubMed ID: 1556180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes.
    Borg H; Marcus C; Sjöblad S; Fernlund P; Sundkvist G
    Acta Paediatr; 2000 Jan; 89(1):46-51. PubMed ID: 10677057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between urinary neopterin excretion and islet cell antibodies in type 1 (insulin-dependent) diabetes.
    Manna R; Salvatore M; Di Leo MA; Scuderi F; Greco AV; Ghirlanda G; Gambassi G
    Diabetes Res; 1991 May; 17(1):33-6. PubMed ID: 1816978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Islet cell and 64K autoantibodies are associated with plasma IgG in newly diagnosed insulin-dependent diabetic children.
    Gerling I; Baekkeskov S; Lernmark A
    J Immunol; 1986 Dec; 137(12):3782-5. PubMed ID: 3537124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.
    Marner B; Agner T; Binder C; Lernmark A; Nerup J; Mandrup-Poulsen T; Walldorff S
    Diabetologia; 1985 Dec; 28(12):875-80. PubMed ID: 3912242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.